We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

GM1 GANGLIOSIDOSIS TREATMENT MARKET ANALYSIS

GM1 Gangliosidosis Treatment Market, by Product Type (LYS-GM101, PBGM01, AXO-AAV-GM1), by Disease Type (Type 1 GM1 Gangliosidosis, Type 2 GM1 Gangliosidosis, and Type 3 GM1 Gangliosidosis), and by Region (North America, Europe and Rest of World ) - Size, Share, Outlook, and Opportunity Analysis, 2025 - 2030

Key Players

Major players operating in the global GM1 Gangliosidosis Treatment market are Axovant Gene Therapies Ltd. and Passage Bio and Lysogene.

Companies covered:

Axovant Gene Therapies Ltd, Passage Bio and Lysogene.

Joining thousands of companies around the world committed to making the Excellent Business Solutions.